Eric has 30 years of clinical research experience. he started his career in 1983 as head trial department of the Comprehensive Cancer Center Amsterdam. Between 1990 and 2000 he has held several positions at companies specialized in electronic data collection systems for clinical research as well as market research for the pharmaceutical industry. In 2000 he joined NDDO Oncology, a spin-off company of the EORTC, where he acted as COO and CEO. After acquisition of NDDO Oncology by INC Research in 2005 Eric became Vice President Oncology for Europe of INC Research. Eric is one of the co-founders of SMS-oncology, a specialized oncology CRO established in 2007. Between 2007 and 2013 Eric has worked as COO and CEO at SMS-oncology.
ISA Pharmaceuticals and Regeneron Announce Strategic Immuno-Oncology Collaboration
Cristal Therapeutics awarded €2.5 million Horizon 2020 grant to advance its CriPec®-docetaxel through Phase 2 trials